Home » AEOLUS GETS $2.5 MILLION FROM INVESTORS
AEOLUS GETS $2.5 MILLION FROM INVESTORS
Existing investors have pumped $2.5 million into Aeolus Pharmaceuticals, a Research Triangle Park drug development company. The investment comes about a week after Aeolus' board of directors hired California consulting firm McManus Financial Consultants, and its president, John McManus. A one-year employment agreement filed with the Securities and Exchange Commission promises John McManus a $75,000 bonus if Aeolus secures at least $5 million in investments.
The News & Observer (http://newsobserver.com/business/story/2542774p-8946727c.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May